Lmr Partners LLP Zynerba Pharmaceuticals, Inc. Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.27 - $4.64 $47,735 - $67,734	-14,598 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.23 - $4.3 $8,320 - $11,076	-2,576 Reduced 15.0%	14,598 $48,000
Q2 2020 Aug 14, 2020	BUY	$3.31 - $6.54 $56,845 - $112,317	17,174 New	17,174 $58,000
Q3 2018 Nov 14, 2018	SELL	$5.59 - $10.45 $179,142 - $334,891	-32,047 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$7.98 - $12.39 $255,735 - $397,062	32,047 New	32,047 $312,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.